gadolinium dtpa has been researched along with methionine in 3 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (methionine) | Trials (methionine) | Recent Studies (post-2010) (methionine) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 27,485 | 530 | 5,020 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dunkl, V; Fink, GR; Galldiks, N; Jacobs, AH; Kracht, LW; Schroeter, M; Ullrich, RT; Vollmar, S | 1 |
| Fujima, N; Hirata, K; Kuge, Y; Manabe, O; Shiga, T; Tamaki, N; Usui, R | 1 |
| Beer, AJ; Coburger, J; Eberhardt, N; König, R; Pala, A; Reske, SN; Scheuerle, A; Schmitz, B; Wirtz, CR | 1 |
3 other study(ies) available for gadolinium dtpa and methionine
| Article | Year |
|---|---|
Imaging of non- or very subtle contrast-enhancing malignant gliomas with [¹¹C]-methionine positron emission tomography.
Topics: Adult; Carbon Radioisotopes; Female; Gadolinium DTPA; Glioma; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2011 |
(11)C-Methionine positron emission tomography may monitor the activity of encephalitis.
Topics: Brain; Contrast Media; Electroencephalography; Encephalitis; Female; Follow-Up Studies; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Methionine; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2012 |
Diagnostic accuracy of intraoperative perfusion-weighted MRI and 5-aminolevulinic acid in relation to contrast-enhanced intraoperative MRI and
Topics: Adult; Aged; Aminolevulinic Acid; Brain Neoplasms; Female; Gadolinium DTPA; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Neoplasm, Residual; Photosensitizing Agents; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tumor Burden | 2019 |